PATENT CLAIM ANALYSIS

Application Number: 15955020
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-01
Patent Classification: ["514", "156000"]

Abstract:
In one embodiment, the present application discloses methods of treating diseases and disorders with sulfasalazine and pharmaceutical formulations of sulfasalazine where the bioavailability of the sulfasalazine is increased. In another embodiment, the present application also provides dosing regimens for treating neurodegenerative diseases and disorders with compositions comprising sulfasalazine.

Claim (Index 30):
The method of  claim 27 , wherein the neurodegenerative disorder is seizures.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 91.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14170405', '15365835', '15365843', '15034489', '14384549']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7853366473881312
- 35 USC 102 Novelty (BERT): 0.5490749828278225
- Combined Prediction Score: 0.7617104809321005
- Mean Citation Score: 412.675926
- Max Citation Score: 586.1804
- Similarity Product: 228.04396774717569

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test